Cargando…
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596619/ https://www.ncbi.nlm.nih.gov/pubmed/33128020 http://dx.doi.org/10.1038/s41375-020-01074-4 |
_version_ | 1783602152529199104 |
---|---|
author | Zent, Clive S. Brady, Michael T. Delage, Carolyne Strawderman, Myla Laniewski, Nathan Contant, Phuong N. Kanagaiah, Preshetha Sangster, Mark Y. Barr, Paul M. Chu, Charles C. Topham, David J. Friedberg, Jonathan W. |
author_facet | Zent, Clive S. Brady, Michael T. Delage, Carolyne Strawderman, Myla Laniewski, Nathan Contant, Phuong N. Kanagaiah, Preshetha Sangster, Mark Y. Barr, Paul M. Chu, Charles C. Topham, David J. Friedberg, Jonathan W. |
author_sort | Zent, Clive S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7596619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75966192020-10-30 Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma Zent, Clive S. Brady, Michael T. Delage, Carolyne Strawderman, Myla Laniewski, Nathan Contant, Phuong N. Kanagaiah, Preshetha Sangster, Mark Y. Barr, Paul M. Chu, Charles C. Topham, David J. Friedberg, Jonathan W. Leukemia Letter Nature Publishing Group UK 2020-10-30 2021 /pmc/articles/PMC7596619/ /pubmed/33128020 http://dx.doi.org/10.1038/s41375-020-01074-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter Zent, Clive S. Brady, Michael T. Delage, Carolyne Strawderman, Myla Laniewski, Nathan Contant, Phuong N. Kanagaiah, Preshetha Sangster, Mark Y. Barr, Paul M. Chu, Charles C. Topham, David J. Friedberg, Jonathan W. Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma |
title | Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma |
title_full | Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma |
title_fullStr | Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma |
title_full_unstemmed | Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma |
title_short | Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma |
title_sort | short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein e during initial btk inhibitor therapy for cll or lymphoplasmacytic lymphoma |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596619/ https://www.ncbi.nlm.nih.gov/pubmed/33128020 http://dx.doi.org/10.1038/s41375-020-01074-4 |
work_keys_str_mv | AT zentclives shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT bradymichaelt shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT delagecarolyne shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT strawdermanmyla shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT laniewskinathan shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT contantphuongn shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT kanagaiahpreshetha shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT sangstermarky shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT barrpaulm shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT chucharlesc shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT tophamdavidj shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma AT friedbergjonathanw shorttermresultsofvaccinationwithadjuvantedrecombinantvaricellazosterglycoproteineduringinitialbtkinhibitortherapyforcllorlymphoplasmacyticlymphoma |